Patents by Inventor Lilian Alicia Radesca

Lilian Alicia Radesca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors
    Patent number: 6348616
    Abstract: The present invention describes novel methods for the synthesis of benzoxazinone compounds which are useful as human immunodeficiency virus (HIV) reverse transcriptase inhibitors. The benzoxazinone of the formula: is particularly effective in the treatment of HIV.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: February 19, 2002
    Inventors: Michael Ernest Pierce, Lilian Alicia Radesca
  • Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors
    Patent number: 6147210
    Abstract: The present invention describes novel methods for the synthesis of benzoxazinone compounds which are useful as human immunodeficiency virus (HIV) reverse transcriptase inhibitors. The benzoxazinone of the formula: is particularly effective in the treatment of HIV.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: November 14, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Michael Ernest Pierce, Lilian Alicia Radesca
  • Asymmetric synthesis of benzoxazinones
    Patent number: 5932726
    Abstract: The present invention provides novel methods for the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1- benzoxazin-2-one of formula (VI-i) ##STR1## which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: August 3, 1999
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Michael Ernest Pierce, Anusuya Choudhury, Rodney Lawrence Parsons, Jr., Lilian Alicia Radesca